November 14, 2019 Exposure to Industrial Air Pollutants Linked to Rheumatoid Arthritis Biomarker ACR Annual Meeting: Exposure to industrial emissions of fine particles matter and sulfur dioxide are associated with the presence of anti-citrullinated protein antibodies (ACPA), a characteristic biomarker for rheumatoid arthritis, according to a study presented at the annual meeting of the American College of Rheumatology in Atlanta on November 12. Read more   ADVERTISEMENT Anifrolumab Shows Efficiency in Systemic Lupus ACR Annual Meeting: In patients with moderate to severe systemic lupus erythematosus, anifrolumab (AstraZeneca) was superior to placebo for overall disease activity, skin disease and oral corticosteroid tapering, among other efficacy endpoints, according to a study presented at the annual meeting of the American College of Rheumatology in Atlanta on November 12. Read more   Conventional Therapy Bests Tapered Therapy in Rheumatoid Arthritis ACR Annual Meeting: In rheumatoid arthritis patients in sustained remission on conventional synthetic disease modifying anti-rheumatic drugs, continued csDMARD therapy with stable doses led to fewer disease activity flares and less frequent radiographic joint damage progression than tapered csDMARD treatment, according to a study presented at annual meeting of the American College of Rheumatology in Atlanta on November 12. Read more